Chemoinformaics analysis of O-HYDROXYPHENYLACETIC-ACID
| Molecular Weight | 440.712 | nRot | 1 |
| Heavy Atom Molecular Weight | 392.328 | nRig | 27 |
| Exact Molecular Weight | 440.365 | nRing | 5 |
| Solubility: LogS | -5.972 | nHRing | 0 |
| Solubility: LogP | 7.886 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 83.7101 |
| nHD | 1 | BPOL | 49.0219 |
| QED | 0.417 |
| Synth | 4.495 |
| Natural Product Likeliness | 3.193 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.048 |
| CACO-2 | -5.206 |
| MDCK | 0.00000864 |
| BBB | 0.133 |
| PPB | 0.999226 |
| VDSS | 0.965 |
| FU | 0.0276615 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.49 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.957 |
| CYP2c9-inh | 0.11 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.517 |
| CYP3a4-inh | 0.152 |
| CYP3a4-sub | 0.248 |
| CL | 1.657 |
| T12 | 0.013 |
| hERG | 0.001 |
| Ames | 0.021 |
| ROA | 0.087 |
| SkinSen | 0.018 |
| Carcinogencity | 0.058 |
| EI | 0.55 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.613 |
| Antiviral | No |
| Prediction | 0.813349 |